doi:10.3969/j.issn.1004-583X.2021.07.018

Abstract

CLC Number:

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2021.07.018

https://huicui.hebmu.edu.cn/EN/Y2021/V36/I7/659

Figures/Tables 1

References 47

[1]	Sharma P, Alsharif S, Fallatah A, et al. Intermediate filaments as effectors of cancer development and metastasis: a focus on keratins, vimentin, and nestin[J]. Cells, 2019,8(5):497-518. doi: 10.3390/cells8050497 URL
[2]	Bernal A, Arranz L. Nestin-expressing progenitor cells: function, identity and therapeutic implications[J]. Cell Mol Life Sci, 2018,75(12):2177-2195. doi: 10.1007/s00018-018-2794-z URL
[3]	Krupkova O Jr, Loja T, Redova M, et al. Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors[J]. Tumour Biol, 2011,32(4):631-639. doi: 10.1007/s13277-011-0162-9 URL
[4]	Panvini FM, Pacini S, Montali M, et al. High nestin expression marks the endosteal capillary network in human bone marrow[J]. Front Cell Dev Biol, 2020,11(8):1-14.
[5]	Xie L, Zeng X, Hu J, et al. Characterization of nestin, a selective marker for bone marrow derived mesenchymal stem cells[J]. Stem Cells Int, 2015,7(6):1-9.
[6]	罗时珂, 廖祥中, 谢东明, 等. 巢蛋白对缺血心肌损伤再修复影响[J]. 赣南医学院学报, 2017,37(2):199-202.
[7]	González-Hernández S, Gómez MJ, Sanchez-Cabo F, et al. Sox17 controls emergence and remodeling of nestin-expressing coronary vessels[J]. Circ Res, 2020,127(11):252-270.
[8]	Brassard-Jollive N, Muller MC, Germain S. In vitro 3D systems to model tumor angiogenesis and interactions with stromal cells[J]. Front Cell Dev Biol, 2020,11(8):1-16.
[9]	Jiang X, Wang J, Deng X, et al. The role of microenvironment in tumor angiogenesis[J]. J Exp Clin Cancer Res, 2020,39(1):1-19. doi: 10.1186/s13046-019-1487-2 URL
[10]	Matsuda Y, Hagio M, Ishiwata T. Nestin: A novel angiogenesis marker and possible target for tumor angiogenesis[J]. World J Gastroenterol, 2013,19(1):42-48. doi: 10.3748/wjg.v19.i1.42 URL
[11]	Klein D, Meissner N, Kleff V, et al. Nestin (+) tissue-resident multipotent stem cells contribute to tumor progression by differentiating into pericytes and smooth muscle cells resulting in blood vessel remodeling[J]. Front Oncol, 2014,1(4):169-180.
[12]	Onisim A, Achimas-Cadariu A, Vlad C, et al. Current insights into the association of nestin with tumor angiogenesis[J]. J BUON, 2015,20(3):699-706.
[13]	林才厚, 陈建屏, 王春华, 等. ZEB1及Nestin在高级别胶质瘤初治及配对复发标本中的表达及临床意义[J]. 福建医科大学学报, 2018,52(6):359-363.
[14]	Zheng ZQ, Chen JT, Zheng MC, et al. Nestin +/CD31 + cells in the hypoxic perivascular niche regulate glioblastoma chemoresistance by upregulating JAG1 and DLL4[J]. Neuro Oncol, 2020,11(29):265.
[15]	Matini AH, Naeini MM, Ardekani HP, et al. Evaluation of nestin and EGFR in patients with glioblastoma multiforme in a public hospital in Iran[J]. Asian Pac J Cancer Prev, 2020,21(10):2889-2894. doi: 10.31557/APJCP.2020.21.10.2889 URL
[16]	Wu B, Sun C, Feng F, et al. Do relevant markers of cancer stem cells CD133 and nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis[J]. J Exp Clin Cancer Res, 2015,34(1):44-56. doi: 10.1186/s13046-015-0163-4 URL
[17]	Lu W J, Lan F, He Q, et al. Inducible expression of stem cell associated intermediate filament nestin reveals an important role in glioblastoma carcinogenesis[J]. Int J Cancer, 2011,128(2):343-351. doi: 10.1002/ijc.v128:2 URL
[18]	Zhang D, Wang J. Nestin is significantly associated with the overall survival of nonsmall cell lung cancer: A meta-analysis[J]. J Cancer Res Ther, 2020,16(4):800-803. doi: 10.4103/0973-1482.204901 URL
[19]	Li S, Lai Y, Fan J, et al. Clinicopathological and prognostic significance of nestin expression in patients with non-small cell lung cancer: a systematic review and meta-analysis[J]. Clin Exp Med, 2017,17(2):161-174. doi: 10.1007/s10238-016-0421-6 URL
[20]	Singh S, Trevino J, Bora-Singhal N, et al. EGFR/Src/Akt signaling modulates SOX2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer[J]. Mol Cancer, 2012,11(1):73-88. doi: 10.1186/1476-4598-11-73 URL
[21]	Schaefer T, Lengerke C. SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond[J]. Oncogene, 2020,39(2):278-292. doi: 10.1038/s41388-019-0997-x URL
[22]	Schieber M, Chandel N. ROS function in redox signaling and oxidative stress[J]. Curr Biol, 2014,24(10):453-462. doi: 10.1016/j.cub.2014.03.034 pmid: 24845678
[23]	Zhang DD. The Nrf2-Keap1-ARE signaling pathway: the regulation and dual function of Nrf2 in cancer[J]. Antioxid Redox Signal, 2010,13(11):1623-1626. doi: 10.1089/ars.2010.3301 URL
[24]	Panieri E, Saso L. Inhibition of the nrf2/keap1 axis: a promising therapeutic strategy to alter redox balance of cancer cells?[J]. Antioxid Redox Signal, 2021,34(18):1428-1483. doi: 10.1089/ars.2020.8146 URL
[25]	Wang J, Lu Q, Cai J, et al. Nestin regulates cellular redox homeostasis in lung cancer through the Keap1-Nrf2 feedback loop[J]. Nat Commun, 2019,10(1):5043-5060. doi: 10.1038/s41467-019-12925-9 URL
[26]	Takakuwa O, Maeno K, Kunii E, et al. Involvement of intermediate filament nestin in cell growth of small-cell lung cancer[J]. Lung Cancer, 2013,81(2):174-179. doi: 10.1016/j.lungcan.2013.04.022 pmid: 23706418
[27]	Zhang X, Xing C, Guan W, et al. Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: A systematic review and meta-analysis[J]. Cancer Cell Int, 2020,5(20):169-186.
[28]	黎胤谋, 李靖, 彭世军. Nestin在乳腺癌中的表达及其与他莫昔芬治疗疗效和预后的关系[J]. 国际肿瘤学杂志, 2019,46(4):205-210.
[29]	Feng W, Liu S, Zhu R, et al. SOX10 induced nestin expression regulates cancer stem cell properties of TNBC cells[J]. Biochem Biophys Res Commun, 2017,485(2):522-528. doi: 10.1016/j.bbrc.2017.02.014 URL
[30]	Tampaki EC, Tampakis A, Nonni A, et al. Nestin and cluster of differentiation 146 expression in breast cancer: Predicting early recurrence by targeting metastasis?[J]. Tumour Biol, 2017,39(3):1-10.
[31]	Krüger K, Stefansson IM, Collett K, et al. Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer[J]. Breast, 2013,22(3):282-288. doi: 10.1016/j.breast.2012.07.008 pmid: 22840462
[32]	Aleksandra N, Jedrzej G, Maria P, et al. Nestin-positive microvessel density is an independent prognostic factor in breast cancer[J]. Int J Oncol, 2017,51(2):668-676. doi: 10.3892/ijo.2017.4057 pmid: 28656248
[33]	Iwamoto T, Booser D, Valero V, et al. Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry[J]. J Clin Oncol, 2012,30(7):729-734. doi: 10.1200/JCO.2011.36.2574 URL
[34]	Sheffield BS, Kos Z, Asleh-Aburaya K, et al. Molecular subtype profiling of invasive breast cancers weakly positive for estrogen receptor[J]. Breast Cancer Res Treat, 2016,155(3):483-490. doi: 10.1007/s10549-016-3689-z URL
[35]	Won JR, Gao D, Chow C, et al. A survey of immunohistochemical biomarkers for basal-like breast cancer against a gene expression profile gold standard[J]. Mod Pathol, 2013,26(11):1438-1450.
[36]	Asleh-Aburaya K, Sheffield BS, Kos Z, et al. Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor[J]. Histopathology, 2017,70(2):185-194. doi: 10.1111/his.13038 pmid: 27402148
[37]	Meisen WH, Dubin S, Sizemore ST, et al. Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapies[J]. Mol Cancer Ther, 2015,14(1):307-314. doi: 10.1158/1535-7163.MCT-14-0659 URL
[38]	Yoo JY, Haseley A, Bratasz A, et al. Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and “Vstat120”-expressing oncolytic virus[J]. Mol Ther, 2012,20(2):287-297. doi: 10.1038/mt.2011.208 URL
[39]	Asleh K, Lyck Carstensen S, Tykjaer Jørgensen CL, et al. Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial[J]. Int J Cancer, 2019,144(10):2578-2586. doi: 10.1002/ijc.v144.10 URL
[40]	Vila AL, Leyva A, Julián Vargas Flores, et al. GIST associated with von recklinghausen disease: report of two cases and review of literature[J]. Ann Med Surg (Lond), 2021,1(62):365-368.
[41]	Wang J, Cai J, Huang Y, et al. Nestin regulates proliferation and invasion of gastrointestinal stromal tumor cells by altering mitochondrial dynamics[J]. Oncogene, 2016,35(24):3139-3150. doi: 10.1038/onc.2015.370 pmid: 26434586
[42]	Kelly CM, Sainz LG, Chi P. The management of metastatic GIST: current standard and investigational therapeutics[J]. J Hematol Oncol, 2021,14(1):2-14. doi: 10.1186/s13045-020-01026-6 URL
[43]	Terada T. Smooth muscles and stem cells of embryonic guts express KIT, PDGFRRA, CD34 and many other stem cell antigens: suggestion that GIST arise from smooth muscles and gut stem cells[J]. Int J Clin Exp Pathol, 2013,6(6):1038-1045.
[44]	冯菲, 马大烈, 刘伟强, 等. 巢蛋白(Nestin)在胃肠道间质瘤组织中的表达及其临床意义[J]. 实用癌症杂志, 2004,19(1):24-26.
[45]	孟鑫, 杜金荣. p53、p21、Nestin在胃肠道间质肿瘤的表达研究[J]. 齐齐哈尔医学院学报, 2010,31(16):15-16.
[46]	Li J, Wang R, Yang L, et al. Knockdown of nestin inhibits proliferation and migration of colorectal cancer cells[J]. Int J Clin Exp Pathol, 2015,8(6):6377-6386.
[47]	Mariusz C, Aleksandra N, Jedrzej G, et al. Comparison of microvessel density using nestin and CD34 in colorectal cancer[J]. Anticancer Res, 2018,38(7):3889-3895. doi: 10.21873/anticanres.12673 URL

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 47

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Sihan, Xiong Hu, Shui Dianya, Gao Xiaozhan, Liu Zewei. Diagnostic of superb microvascular imaging for breast tumors: A meta-analysis [J]. Clinical Focus, 2024, 39(2): 108-114.
[2]	Zhao Xuhui, Huang Xiaomin, Da Dezhuan, Xu Yan, Cui Xiaodong, Li Hongling. Screening of glycolysis-related genes for predicting the prognosis of patients with gastric cancer: Based on bioinformatics [J]. Clinical Focus, 2024, 39(1): 20-29.
[3]	Huang Saihu, Long Zhongjie, Dong Xingqiang, Meng Xiangying, Wu Shuiyan, Bai Zhenjiang. Pathogen and clinical characteristics of children with hematologic neoplasms complicated with sepsis [J]. Clinical Focus, 2024, 39(1): 38-42.
[4]	Liu Lili, Yuan Yuting, Lai Gengliang, Tian Chuan, Lan Xiang, Ye Zhonglv. The relationship between minimal residual disease on day 15 and prognosis in children with acute lymphoblastic leukemia [J]. Clinical Focus, 2024, 39(1): 47-52.
[5]	Yi Peng, Li Cuiling, Huang Xinjiang, Zeng Chunhua. Clinical analysis of 5 cases with precocious puberty caused by hypothalamic hamartomas treated with gonadotropin releasing hormone analogues [J]. Clinical Focus, 2024, 39(1): 53-56.
[6]	Zhu Chenglou, Wu Qiong, Da Mingxu. Risk assessment of pancreatic cancer in patients with type 2 diabetes mellitus treated with sitagliptin: A meta-analysis of randomized controlled trials [J]. Clinical Focus, 2023, 38(12): 1061-1066.
[7]	Tao Jianan, Li Wenqian, Ma Xiuwen, An Qi, Wang Xuehong. Meta-analysis of expression and clinical significance of HER-2 in hepatocellular carcinoma [J]. Clinical Focus, 2023, 38(12): 1067-1072.
[8]	Wang Junhong, Gao Zhenhua, Zhang Ronglong, Ji Haomin, Zhao Xinke, Da Mingxu. Quality analysis of the literatures associated with gastric cancer diagnosis from 1980-2021——A bibliometric analysis based on the Web of Science database [J]. Clinical Focus, 2023, 38(12): 1117-1124.
[9]	Zhang Na, Sun Yue, Dong Han, Zhao Peng, Yang Xin, Qi Yuan, Wang Lingling. Correlation between the expression level of SPARC and prognosis in patients with non-small cell lung cancer: A meta-analysis [J]. Clinical Focus, 2023, 38(11): 972-978.
[10]	. [J]. Clinical Focus, 2023, 38(11): 1048-1052.
[11]	. [J]. Clinical Focus, 2023, 38(10): 954-960.
[12]	Lyu Chang, Zhou Liming. Correlation between the TNF-α-308 gene polymorphism and gastric cancer susceptibility: A meta-analysis [J]. Clinical Focus, 2023, 38(9): 779-787.
[13]	Dong Zhengrong, Tao Qianshan, Shen Yuanyuan, Dong Yi. Analysis of the follow-up results of 163 patients with acute promyelocytic leukemia [J]. Clinical Focus, 2023, 38(9): 813-818.
[14]	Hou Youling, Li Yi, Guan Hongyu, Luo Hongxia. Effect of goal-directed fluid therapy on brain tumor resection: A systematic review and meta-analysis [J]. Clinical Focus, 2023, 38(8): 686-693.
[15]	Yang Wei, He Chendong. Primary pulmonary mucosa-associated lymphoid tissue lymphoma with dry cough as the only symptom: A case and literature review [J]. Clinical Focus, 2023, 38(7): 623-627.